Non-Current Assets
Other Non-Current Assets
Pfizer Other Non-Current Assets increased by 2.1% to $9.83B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 0.1%, from $9.85B to $9.83B. Over 5 years (FY 2020 to FY 2025), Other Non-Current Assets shows an upward trend with a 14.6% CAGR.
Analysis
StatementBalance Sheet Statement
SectionNon-Current Assets
CategoryOther
SignalContext dependent
VolatilityStable
First reportedQ4 2014
Last reportedQ1 2026May 5, 2026
How to read this metric
Significant changes may indicate shifts in long-term operational strategy or changes in accounting for specific non-core assets.
Detailed definition
This captures miscellaneous long-term assets that do not fit into specific categories like property, plant, equipment, o...
Peer comparison
Varies widely by company; usually represents a small percentage of total assets.
Metric ID:
non_current_assets_other_assets_noncurrentHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $6.06B | $6.71B | $7.68B | $7.88B | $7.66B | $10.89B | $13.16B | $12.97B | $13.03B | $8.81B | $12.47B | $11.20B | $10.71B | $10.49B | $9.82B | $9.85B | $9.46B | $9.32B | $9.63B | $9.83B |
| QoQ Change | — | +10.7% | +14.5% | +2.6% | -2.8% | +42.2% | +20.9% | -1.5% | +0.5% | -32.4% | +41.6% | -10.2% | -4.3% | -2.1% | -6.4% | +0.3% | -4.0% | -1.5% | +3.4% | +2.1% |
| YoY Change | — | — | — | — | +26.5% | +62.4% | +71.4% | +64.6% | +70.1% | -19.1% | -5.3% | -13.6% | -17.8% | +19.1% | -21.3% | -12.1% | -11.7% | -11.1% | -1.9% | -0.1% |
Range$6.06B – $13.16B
CAGR+10.7%
Avg YoY Growth+12.5%
Median YoY Growth-3.6%
Current Streak2 quarters growth
Other Non-Current Assets at Other Companies
Frequently Asked Questions
- What is Pfizer's other non-current assets?
- Pfizer (PFE) reported other non-current assets of $9.83B in Q1 2026.
- How has Pfizer's other non-current assets changed year-over-year?
- Pfizer's other non-current assets decreased by 0.1% year-over-year, from $9.85B to $9.83B.
- What is the long-term trend for Pfizer's other non-current assets?
- Over 5 years (2020 to 2025), Pfizer's other non-current assets has grown at a 14.6% compound annual growth rate (CAGR), from $4.88B to $9.63B.
- What does other non-current assets mean?
- Miscellaneous long-term assets that do not fall into standard reporting categories.